Clinical Trials
489 articles
Participating in clinical trials can give you access to the latest treatments for pancreatic cancer.
A Clinical Trial Saved My Life
Bob Minetti and his doctors believe that a clinical trial saved his life after a pancreatic cancer diagnosis.
Lots and Lots of Research Leads to a Better Outcome
Dan Grunfeld put his experience as a chemist to good use as he researched pancreatic cancer treatments to find a clinical trial.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Treatment Options
Treatment Options After you are diagnosed, your oncologist will discuss treatments. Learn more about the different types of chemotherapy, surgery, and radiation used to treat pancreatic cancer. Chemotherapy Most pancreatic cancer patients receive some type of chemotherapy, no matter what the stage of disease, to stop or slow the cancer from growing. Chemotherapy can cause […]
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Immunotherapy to Help Shrink Pancreatic Tumors for Surgery
Researchers are looking at adding checkpoint drugs–a type of immunotherapy–to standard chemoradiation to shrink pancreatic cancer for surgery.
Testing the Effectiveness of Radiation and Standard Treatment
A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.
Maintenance Chemotherapy for Stable Metastatic Pancreatic Cancer
A clinical trial tests the diabetes drug metformin and transplant rejection preventative rapamycin to act as maintenance chemotherapy for pancreatic cancer.
Immunotherapy for Pancreatic Neuroendocrine Tumors
A clinical trial combines the immunotherapy drug pembrolizumab with lanreotide, a drug typically used to treat pancreatic neuroendocrine tumors.
Finding the Best Dose of Radiation and an Experimental Drug
A clinical trial looks for the best dose of an experimental drug to combat the mouth sores that are a side effect of stereotactic body radiation therapy.